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bjectives We investigated the reliability of fractional ﬂow reserve (FFR) of nonculprit coronary ste-
oses during percutaneous coronary intervention (PCI) in acute myocardial infarction.
ackground Assessing the hemodynamic severity of the nonculprit coronary artery stenoses at the
cute phase of a myocardial infarction could improve risk stratiﬁcation and shorten the diagnostic
ork-up.
ethods One hundred one patients undergoing PCI for an acute myocardial infarction (n  75
ith ST-segment elevation myocardial infarction [STEMI], and n  26 with non–ST-segment eleva-
ion myocardial infarction) were prospectively recruited. The FFR measurements in 112 nonculprit
tenoses were obtained immediately after PCI of the culprit stenosis and were repeated 35  4 days
ater. In addition, left ventricular ejection fraction, quantitative coronary angiographic measurements
f the nonculprit stenoses, Thrombolysis In Myocardial Infarction (TIMI) ﬂow, corrected TIMI frame
ount (cTFC), and the index of microcirculatory resistance (n  14) of the nonculprit vessels were
ssessed in the acute phase and at control angiogram.
esults The FFR value of the nonculprit stenoses did not change between the acute and follow-up
0.77  0.13 vs. 0.77  0.13, respectively, p  NS). In only 2 patients, the FFR value was higher than
.8 at the acute phase and lower than 0.75 at follow-up. The TIMI ﬂow, cTFC, percentage diameter
tenosis, minimum lumen diameter, and index of microcirculatory resistance did not change. Left
entricular ejection fraction increased signiﬁcantly in patients with STEMI (from 54  13% to 57 
3%, p  0.03).
onclusions During the acute phase of acute coronary syndromes, the severity of nonculprit coro-
ary artery stenoses can reliably be assessed by FFR. This allows a decision about the need for addi-
ional revascularization and might contribute to a better risk stratiﬁcation. (J Am Coll Cardiol Intv
010;3:1274–81) © 2010 by the American College of Cardiology Foundation
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1275hether microvascular function during an acute myocardial
nfarction (MI) is abnormal in remote myocardial areas
emains unclear. Therefore, the assessment of stenoses in
he “nonculprit” arteries is generally postponed to a later
tage. Yet, multivessel coronary artery disease is present in
pproximately one-half of patients with an acute MI (1–4).
his finding is associated with a worse clinical outcome (2).
ome data suggest that revascularization of nonculprit
oronary artery stenoses during the first month after primary
ercutaneous coronary intervention (PCI) might result in a
ignificant survival benefit (2).
See page 1282
In these studies, however, the presence of multivessel
oronary artery disease was defined by visual estimation of
he stenoses. Precise assessment of the hemodynamic sever-
ty of nonculprit coronary artery stenoses with fractional
ow reserve (FFR) during the acute phase of an MI could
mprove risk stratification and shorten the duration of
ospital stay by decreasing the need for additional nonin-
asive stress testing to detect residual myocardial ischemia.
The goal of the present study was to assess the reliability
f FFR in nonculprit coronary artery stenoses during the
cute phase of acute coronary syndromes (ACS). Therefore
e measured FFR in nonculprit coronary artery stenoses
uring the acute phase of an MI and repeated these
easurements within 3 months.
ethods
tudy patients. The study was prospectively conducted at 4
nstitutions. Patients were included in the study if they
ulfilled the following criteria: 1) the presence of an acute
T-segment elevation myocardial infarction (STEMI)
reated by primary PCI or a non–ST-segment elevation
yocardial infarction (NSTEMI) scheduled for PCI of the
ulprit stenosis within 72 h after the onset of chest pain;
) the presence of at least 1 nonculprit coronary artery
tenosis in which PCI was contemplated on the basis of the
ngiogram (more than 50% diameter stenosis [%DS] by
isual estimate); and 3) stable hemodynamic condition.
tudy protocol. ACUTE PHASE. A biplane coronary angiog-
aphy was obtained after administration of nitrates. The
ulprit stenosis was identified on the basis of electrocardio-
raphic and angiographic data. A PCI of the culprit lesion
as performed according to local routine. Thrombus aspi-
ation, antiplatelet treatment, as well as stent implantation
nd the type of the stent were left to the discretion of the
perator. Thereafter, a high-quality angiogram focusing on
he nonculprit coronary artery stenoses was repeated to
easure reference diameter, minimum lumen diameter, and
DS by quantitative coronary angiography (ACOM PC s.01, Siemens Medical Systems, Inc., Malvern, Pennsylva-
ia) as previously described (5). Thrombolysis In Myocar-
ial Infarction (TIMI) flow and corrected TIMI frame
ount of the nonculprit coronary artery stenoses were
ssessed as well, after nitrate administration before position-
ng the pressure wire for the FFR measurements. All
ngiographic parameters were quantified offline by 2 inde-
endent operators. Either at the beginning (54%) or at the
nd (46%) of the catheterization a biplane left ventricular
ngiogram was acquired. Left ventricular volumes and left
entricular ejection fraction (LVEF) were calculated accord-
ng to the Simpson’s method. Left ventricular end diastolic
ressure (LVEDP) was also recorded before and after left
entricular angiography.
FR. The FFR was assessed in
onculprit coronary artery ste-
oses as follows: after another
dministration of 200 g of iso-
orbide dinitrate, a pressure-
onitoring guidewire (Pressure-
ire Certus, St. Jude Medical
ystems AB, Uppsala, Sweden)
as advanced distal to the ste-
osis. Hyperemia was obtained
fter administration of intrave-
ous (140 g/kg/min, n  14)
r intracoronary adenosine (Bo-
us of 50 g, n  87). By pro-
ocol, the route of adenosine ad-
inistration was left at the
iscretion of each operator, be-
ause both intravenous and in-
racoronary adenosine induce a
imilar degree of hyperemia in
umans, provided sufficient
oses are used (6). When the
ntracoronary route was used,
he measurements were done in
uplicate, and the average value
as recorded. The exact position
f the sensor was filmed to enable the operator to position
he sensor in the exact same place at control angiography.
he FFR was automatically calculated by dividing the mean
istal coronary artery pressure by the mean aortic pressure
uring maximal hyperemia.
icrovascular function. In a subgroup of 14 patients studied
t 1 site (Aalst), the microvascular function of the territory
upplied by the nonculprit coronary artery measured by FFR
as assessed with the thermodilution-derived index of
icrocirculatory resistance (IMR), as described by Fearon et
l. (7). Briefly, the pressure/temperature sensor of the
ertus PressureWire (St. Jude Medical Systems AB) was
ositioned in the distal third of the artery. During steady
Abbreviations
and Acronyms
%DS  percentage diameter
of stenosis
ACS  acute coronary
syndromes
FFR  fractional flow
reserve
IMR  index of
microcirculatory resistance
LVEDP  left ventricular end
diastolic pressure
LVEF  left ventricular
ejection fraction
MI  myocardial infarction
NSTEMI  non–ST-segment
elevation myocardial
infarction
PCI  percutaneous
coronary intervention
STEMI  ST-segment
elevation myocardial
infarction
TIMI  Thrombolysis In
Myocardial Infarctiontate hyperemia obtained by intravenous administration of
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1276denosine, a coronary thermodilution curve was obtained by
olus injection of 3 to 4 ml of saline at room temperature.
n stenoses with an FFR value larger than 0.75, the IMR
as calculated as the product of mean distal coronary
ressure and mean hyperemic transit time. In stenoses with
n FFR value of 0.75, IMR was calculated as the product
f mean aortic pressure, mean hyperemic transit time, and
he FFR value (8).
IOCHEMICAL PARAMETERS. Peak total creatinine phos-
hokinase was measured at the acute phase as an estimate of
he extent of myocardial damage.
ollow-up. Four days to 3 months later, the patients under-
ent a second catheterization. The LVEDP was recorded,
nd a biplane left ventricular angiogram was also performed.
oronary angiography of both culprit and nonculprit vessels
fter intracoronary isosorbide dinitrate was obtained in the
ame projections as during the acute phase. The FFR
easurements were repeated after reviewing the angiogram
btained at the acute phase to ensure the exact same
osition of the pressure-monitoring guidewire. In patients
n whom IMR had been obtained, these measurements were
epeated as well.
The treatment of the nonculprit stenosis was left to the
iscretion of the operator and guided by FFR. Quantitative
oronary angiography was performed offline and blinded to
he FFR results. All angiographic measurements reported in
his study are derived from quantitative coronary angiogra-
hy. All analyses of FFR and IMR were done on a
er-stenosis basis.
tatistical analysis. Statistical analysis was performed with
he GraphPad Prism 5 Software (La Jolla, California).
ontinuous variables are summarized as mean  SD.
aired and unpaired samples t tests were used to analyze
ifferences in continuous variables with normal distribution,
nd Mann-Whitney U test was used for continuous vari-
bles with non-Gaussian distribution. Categorical variables
re expressed as frequencies and percentages. Chi-square
nd Fisher exact test were used for the comparison of
ategorical variables. Bland-Altman analysis was used for
he estimation of the reproducibility of the FFR and
DS. Pearson and Spearman tests were used for the
orrelation of Gaussian and non-Gaussian distributed
ariables, respectively. Clinical data as well as hemody-
amic and angiographic parameters were compared be-
ween STEMI and NSTEMI subgroups and between
cute phase and follow-up in both subgroups. A p value
0.05 was considered statistically significant.
esults
aseline characteristics. One hundred twelve patients (85
TEMI, and 27 NSTEMI) were prospectively included. In
3 patients, 2 lesions were studied. From them, 3 patients
ied, and 8 other patients withdrew consent before the collow-up measurements. Finally, 112 nonculprit stenoses
ith a %DS between 30% and 91% were evaluated in 101
atients. An intermediate stenosis (40% to 70%) was present
n most of the cases (71%, n  79 nonculprit stenoses).
The clinical, procedural, biological, and angiographic
haracteristics of patients with STEMI and NSTEMI
uring the acute phase are listed in Table 1. The mean
uration of symptoms to PCI was 230  201 min for
TEMI and 52 45 h for NSTEMI. Door to balloon time
or the STEMI group was 35  33 min. Thrombus
spiration was used more often in STEMI patients. History
f arterial hypertension and hyperlipidemia was more fre-
uent among the NSTEMI group. Higher creatinine phos-
hokinase values were observed in the STEMI group. The
DS and minimum lumen diameter of the nonculprit stenoses
ssessed by FFR were similar in STEMI and NSTEMI
atients. After PCI of the culprit, TIMI flow grade 3 in the
evascularized vessel was present in 96% and 89% of the
TEMI and NSTEMI patients, respectively.
ollow-up data. Follow-up catheterization was performed
5  4 days (median 27 days, range 4 to 128 days) after the
cute phase. Table 2 shows the hemodynamic, angio-
raphic, and physiological parameters at the acute and
ollow-up phases.
The LVEDP and LVEF did not change significantly
etween acute and follow-up phase. However, when only
atients with STEMI were considered, a modest but sig-
ificant decrease in LVEDP (19  8 vs. 18  6 mm Hg,
 0.05) and an increase in global LVEF (54  13% vs.
7  13%, p  0.05) were observed.
As shown in Figure 1, FFR remained unchanged between
cute and follow-up phases in patients with STEMI (0.78 
.10 vs. 0.76  0.10, respectively, p  NS) and NSTEMI
0.77  0.10 vs. 0.77  0.20, respectively, p  NS),
lthough in 2 patients, the FFR value was higher than 0.8
uring the acute phase and lower than 0.75 at follow-up.
Similarly, in “angiographically intermediate stenoses”
40% to 70%), FFR did not change significantly between
he acute and follow-up phases (0.79  0.10 vs. 0.78 
.10, p  NS, median change of: 0.02, range: 0.04 to
0.02).
When only patients in the lowest quartile of LVEF at the
cute phase were considered, the significant increase in
VEF at follow-up (from 42  8% to 51  12%, p 
.005) was not paralleled by a change in FFR of the
onculprit stenoses (0.82  0.10 vs. 0.81  0.10, p  NS)
Fig. 2).
In most of the patients (83%, n 85) FFR was reassessed
ore than 7 days after the acute phase. Nevertheless, FFR
id not change significantly whether the follow-up mea-
urements were performed 7 days (0.79  0.10 vs. 0.79 
.09, p  NS) or more than 7 days after the acute phase
0.77  0.10 vs. 0.77  0.10, p  NS). The median FFR
hange between acute phase and follow-up was 0.02
(
i

d
p
c
(
s
T
i
c
p
D
T
n
c
s
s
F
p
a
r
t
d
t
t
i
C
p
s
d
f
s
s
t
t
r; RCA
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 3 , N O . 1 2 , 2 0 1 0 Ntalianis et al.
D E C E M B E R 2 0 1 0 : 1 2 7 4 – 8 1 FFR of Nonculprits in Acute MI
1277range: 0.06 to 0.02) in patients with FFR reassessment
n a time period of 7 days and 0.014 (range: 0.03 to
0.20) in patients with FFR reassessment in more than 7
ays (p  NS).
The reproducibility of the FFR values measured in acute
hase and at follow-up, was superior (r 0.91, p 0.0001)
ompared with the reproducibility of the angiographic %DS
r  0.78, p  0.0001) (Fig. 3).
The IMR of the territory depending on the nonculprit
tenoses was obtained in a subgroup of patients (n  14).
he IMR values were found in the normal range (30 IU)
Table 1. Clinical, Procedural, Biological, and Angiographic Characteristics
Characteristics All Patients (n  101)
Age (yrs)* 63 12
Men/women 79/21
BMI (kg/m2)* 28 4
Arterial hypertension 57
Current smoker 41
Hyperlipidemia 50
Diabetes mellitus 11
Family history of CAD 20
Anterior infarction 25
BMS/DES (culprit) 80/20
Thrombus aspiration 36
GP IIb/IIIa inhibitors 23
CPKmax (IU/ml)† 464 (193–1,018)
Culprit: LAD/LCX/RCA/other 23/27/45/6
Nonculprit: LAD/LCX/RCA/other 56/18/21/5
DS nonculprit* 56 14
MLD nonculprit (mm)* 1.32 0.46
Values are percentages, unless otherwise indicated. *Mean SD;†median (interquartile range). The
and non–ST-segment elevation myocardial infarction (NSTEMI) groups.
BMI bodymass index; BMS bare-metal stent(s); CAD coronary artery disease; CPK creatin
anterior descending coronary artery; LCX left circumflex artery; MLDminimum lumen diamete
Table 2. Angiographic, Hemodynamic, and Functional Measurements
of Nonculprit Stenoses in Acute Phase and at Follow-Up in All
Study Patients
Acute Phase
(n  101)
Follow-Up
(n  101) p Value
LVEF (%) 59 15 61 14 NS
LVEDP (mm Hg) 18 7 17 7 NS
FFR nonculprit 0.77 0.13 0.77 0.13 NS
IMR nonculprit (IU) 20 3 24 6 NS
DS nonculprit (%) 56 14 55 14 NS
MLD nonculprit (mm) 1.32 0.46 1.31 0.50 NS
RD nonculprit (mm) 2.9 0.70 2.7 0.70 NS
TIMI ﬂow nonculprit 2.93 0.30 2.97 0.20 NS
cTFC nonculprit 15 6 15 6 NS
Values are mean SD.
cTFC corrected TIMI frame count; DS diameter of stenosis; FFR fractional flow reserve;
IMR  index of microcirculatory resistance; LVEDP  left ventricular end-diastolic pressure;iLVEF left ventricular ejection fraction;MLDminimum lumendiameter; RD referencediameter.n 11 of 14 patients (79%). In addition, these values did not
hange significantly between the acute and the follow-up
hase (Table 2).
iscussion
he present data indicate that FFR measurements in
onculprit coronary artery stenoses do not change signifi-
antly when measured during the acute phase of a MI and
ome days or weeks later. These findings suggest that the
everity of nonculprit stenoses can reliably be assessed by
FR during the setting of primary PCI. In only 2% of
atients, the change in FFR value between the acute phase
nd the control angiogram might have induced a change in
evascularization strategy. The microvascular dysfunction
hat had been described in the contralateral territories
uring the early weeks after an acute MI was not found in
he present study. Furthermore, in comparison with quan-
itative coronary angiography, FFR showed less variability
n assessing the nonculprit stenoses.
linical signiﬁcance of the nonculprit stenoses in ACS. In
atients with acute MI and 1 or more angiographically
ignificant nonculprit coronary artery stenoses, the inci-
ence of heart failure (9), recurrent ACS (10), and need for
urther revascularization (10,11) has been reported to be
ignificantly higher, and survival has been reported to be
ignificantly lower (2,12). In addition, recent data indicate
hat revascularization of these nonculprit stenoses within
he first month after the acute phase of the index MI
Study Population, STEMI, and NSTEMI Subgroups During the Acute Phase
STEMI (n  75) NSTEMI (n  26) p Value
64 12 61 12 NS
81/19 74/26 NS
28 4 28 4 NS
49 78 0.0001
43 33 NS
41 78 0.0001
11 12.5 NS
21 15 NS
24 26 NS
79/21 81/19 NS
46 11 0.0001
23 22 NS
818 (455–2,097) 235 (136–4,437) 0.0001
24/24/49/3 22/38/33/7 0.001
58/20/17/5 52/14/31/7 0.044
56 14 56 15 NS
1.29 0.48 1.44 0.38 NS
s indicate the statistical difference between the ST-segment elevationmyocardial infarction (STEMI)
sphokinase; DES drug-eluting stent(s); DS diameter of stenosis; GP glycoprotein; LAD left
right coronary artery.of All
p value
ine phomproves survival (2). In contrast, in patients with a recent
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1278I, nonsignificant nonculprit stenoses have been shown to
arely progress, even in the “pre-statin” era (13). Work by
ioufol et al. (14) demonstrated that, in patients with an
CS, more than 1 ruptured plaque in the nonculprit vessel
ould be identified but that only the lesions with a hemo-
ynamically significant narrowing were responsible for clin-
cal events.
In stable patients, the long-term clinical outcome of
emodynamically nonsignificant stenoses has been shown to
e excellent and is not improved by PCI (15). The recent
AME (Fractional Flow Reserve versus Angiography for
uiding PCI in Patients with Multivessel Coronary Artery
isease) trial confirms this approach in patients with
ultivessel disease (16). Therefore, the assessment of the
ctual severity of the nonculprit coronary artery stenoses is
linically important soon after primary PCI. Because the
ngiographic assessment of lesion severity is notoriously
naccurate (17,18), the functional assessment of these le-
ions is traditionally performed by noninvasive testing in the
rst days or weeks after primary PCI. These tests, however,
ften prolong hospital stay (19), are expensive, and are often
ifficult to perform or interpret soon after the acute event,
nd eventually a second catheterization is required. There-
ore, measuring FFR of the nonculprit stenoses in the
Figure 1. Plot of FFR Values of Nonculprit Coronary Artery Stenoses
During the Acute Phase and at Follow-Up
FFR  fractional ﬂow reserve; NS  not statistically signiﬁcant.etting of primary PCI might be an interesting alternative.FR as an alternative to noninvasive testing in ACS. Like
yocardial perfusion imaging, FFR assesses the impact of
n epicardial stenosis on myocardial perfusion. The major
dvantages of FFR are its reproducibility, higher specificity,
nd unsurpassed spatial resolution. In addition, it can be
btained in a few minutes in the catheterization laboratory
i.e., at the very place where the revascularization can be
pplied) (20). Yet, to be valid, FFR should be obtained
uring maximal microvascular dilation. Animal experiments
howed focal myocardial necrosis and regional derange-
ents in lactate metabolism in the nonculprit areas (21,22).
arlier human studies using positron emission tomography
23), angiography (corrected TIMI frame count) (24), and
he Doppler wire (25) have suggested significant microvas-
ular dysfunction of both culprit and nonculprit areas during
he acute phase of a STEMI. Extensive ischemia in adjacent
erritories, vasoconstriction mediated by local neurohumoral
eflexes (26), and elevated LVEDP (25) were considered as
ossible underlying pathophysiologic mechanisms for the
nterpretation of these findings. Other experimental (27–29)
nd clinical investigations (23,30) concluded that even the
resence of subendocardial ischemia was sufficient to induce
ignificant microvascular dysfunction remote to the isch-
mic territory. In contrast, in chronic MI, recent data
uggest that microvascular function in the nonculprit terri-
ories is normal (31).
Figure 2. Plot of FFR Values of Nonculprit Coronary Artery Stenoses
During the Acute Phase and at Follow-Up in Patients on the Lowest
LVEF Quartile
Mean left ventricular ejection fraction (LVEF) of 42  8% at the acute
phase increasing to 51  12% at control angiography. Abbreviations as in
Figure 1.
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1279In the present study, microvascular function was directly
ssessed in a subgroup of patients with IMR, an index
pecific for the microvasculature (7). This index was normal
n the nonculprit territories even during the acute phase of
arge MIs. The value of IMR did not change significantly
fter a few days or weeks, suggesting that if some degree of
icrovascular dysfunction was present it was not related to
he adjacent MI but rather to the atherosclerotic process.
he absence of significant reversible microvascular dysfunc-
ion constitutes the basis of the reliability of FFR in
ssessing nonculprit coronary artery stenoses in patients
ith ACS.
tudy limitations. The absence of changes in microvascular
unction reported in the present study might be related to
he relatively short (median 27 days) delay between the 2
easurements. Several studies have indicated that micro-
ascular dysfunction might persist up to 3 months in
emote, noninfarcted territories after an acute MI (23,32).
herefore, it cannot be excluded that the absence of changes
bserved in the present study actually corresponds to a
onstant derangement of the microvasculature in the 2 time
oints assessed.
In most cases (STEMI and NSTEMI), the infarction
Figure 3. Bland-Altman Analysis and Correlation for FFR and %DS
(A) Bland-Altman plot displaying the changes in fractional ﬂow reserve (FFR) b
correlation of the FFR values between the acute and follow-up phases. (C) Bla
between the acute and follow-up phases versus the average value of diamete
(A) and %DS (C), respectively. (D) Plot of correlation of the %DS values betweas located in the inferior and lateral wall. Also, patients Honsidered “hemodynamically unstable” were excluded.
herefore these results should be applied with caution to
atients with extensive necrosis and cardiogenic shock.
owever, in these patients, the need for measuring the
ignificance of a nonculprit stenosis is exceptional. It is also
ood clinical practice not to induce hyperemia in hemody-
amically unstable patients.
Nonculprit stenoses with an FFR of 0.80 underwent
CI at follow-up catheterization, whereas the other steno-
es were treated medically. The present study was not
owered to investigate differences in clinical outcome.
arger trials should be performed to address this question.
The results of this study do not suggest that the noncul-
rit stenoses should be revascularized during the acute phase
f an MI. At present, multivessel revascularization in the
cute phase of an MI should be contemplated only in
atients with cardiogenic shock and critical nonculprit
tenoses (33).
dvantages and disadvantages of measuring FFR at the acute
hase of an acute MI. Measuring FFR will prolong the
rocedure. This time depends mainly on the experience of
he laboratory with this kind of measurement. Also the
mounts of contrast medium and of radiation will be higher.
n the acute and follow-up phases versus the average FFR value. (B) Plot of
man plot displaying the changes in percentage diameter stenosis (%DS)
sis. The dotted lines correspond to  2 SDs of the average values of FFR
acute and follow-up phases.etwee
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r stenoowever, this should be largely offset by the reduced need
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1280or noninvasive imaging and repeat catheterization in many
atients. In addition, the feasibility and accuracy of nonin-
asive measurement soon after an MI, especially in patients
ith multivessel disease, is low (34). Therefore, FFR mea-
urements performed in the setting of primary PCI of the
ulprit lesion should minimize the need for additional
iagnostic work-up.
onclusions and Clinical Implications
ven though FFR measurements should be discouraged in
CS to evaluate culprit stenoses, the present data support
hat FFR measurements are safe and reliable for evaluating
he actual severity of nonculprit stenoses during primary
CI. In addition to coronary anatomy and left ventricular
unction, FFR can thus provide accurate functional in-
ormation on nonculprit stenoses even during the acute
hase of an acute MI. It is hypothesized that early
ssessment of residual myocardial ischemia in the setting
f primary PCI might improve risk stratification and
asten clinical decision-making about the need for addi-
ional revascularization. This might indeed decrease the
eed for further noninvasive testing or repeated catheter-
zation and therefore shorten diagnostic work-up after
n MI.
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